The rationale was explained at the AGM. mRNA vaccines or drugs induce inflammation courtesy of the TLR-7 receptor. Moderna and Pfizer/BioNTech have exclusive licence to the technology invented by the two recent Nobel Prize winners to help block the inflammatory response. All other companies interested in mRNA vaccines or drugs have been locked out of that technology and need to find another way to allow them onto the market. NOX believes that it has the only other way. So, I take it from that explanation that prospective Licensees are everyone else apart from Moderna and Pfizer/BioNTech.
- Forums
- ASX - By Stock
- NOX
- Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction, page-46
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $5.653K | 48.83K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 22101 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 159073 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 22101 | 0.115 |
2 | 75461 | 0.110 |
4 | 445000 | 0.105 |
6 | 244077 | 0.100 |
1 | 6000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 159073 | 5 |
0.125 | 144133 | 5 |
0.130 | 409378 | 5 |
0.135 | 205000 | 2 |
0.140 | 227281 | 6 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |